Skip to main content
Premium Trial:

Request an Annual Quote

Singapore's Prolaris Gets Illumina CSPro Certification

NEW YORK (GenomeWeb News) – The Prolaris laboratory of the Genome Institute of Singapore said today that it has received Illumina certified service provider certification for sequencing using Illumina's products.

According to Prolaris COO Christopher Wong, Prolaris is the first lab in South-East Asia to receive Illumina CSPro certification for sequencing. The lab is funded by Singapore's Agency for Science, Technology and Research and provides a variety of omics services.

Participants in the Illumina CSPro program are required to undergo a two-phase certification process that includes minimum data generation, data certification, and an on-site audit of a facility and its processes.

Other members of the Illumina CSPro program for sequencing include MOgene, Aalacris Theranostics, Personalis, LGC Genomics, and Expression Analysis.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.